selected scholarly activity
-
chapters
- Late-Life Anxiety Disorders. 253-264. 2018
- Substance Use Disorders in Late Life. 319-342. 2018
-
conferences
- Systematic Review and Meta-Analysis of the Association between FTO rs9939609 Obesity Polymorphism and Suicide in a Large-Scale Multiethnic Population. Genetic Epidemiology. 672-673. 2017
- Chronic pain in patients with opioid use disorder receiving methadone. Journal of the Neurological Sciences. 165-165. 2017
- The Role of Testosterone in Men and Women Undergoing Methadone Maintenance Treatment (MMT) for Opioid Addiction. Biological Psychiatry. 396S-396S. 2014
- Examination of the Mechanisms of Weight Gain in Patients with Depression. Biological Psychiatry. 184S-184S. 2011
-
journal articles
- Do we need urine drug screens in opioid addiction treatment: An observational study on self-report versus urine drug screens. Addictive Behaviors Reports. 21:100575. 2025
- Health service utilization, substance use treatment response, and death in patients with opioid use disorder and comorbid hepatitis C findings from prospective cohort study with administrative database linkage.. Journal of Substance Use and Addiction Treatment. 167:209524. 2024
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes. Canadian Journal of Psychiatry. 69:641-687. 2024
- Less focus on symptom scales in psychiatric trials: it is time to ensure research equality between psychiatry and other medical specialities. The Lancet Regional Health - Europe. 43:100993-100993. 2024
- Components of Outpatient Child and Youth Concurrent Disorders Programs: A Critical Interpretive Synthesis: Composantes des programmes de troubles concomitants des enfants et des jeunes ambulatoires : une synthèse interprétative critique. Canadian Journal of Psychiatry. 69:381-394. 2024
- Patient perspectives on pharmacogenomic (PGx) testing for antidepressant prescribing in primary care: a qualitative description study. Journal of Community Genetics. 15:293-309. 2024
- Assessing fragility of statistically significant findings from randomized controlled trials assessing pharmacological therapies for opioid use disorders: a systematic review. Trials. 25:286. 2024
- Primary outcome reporting in clinical trials for older adults with depression. BJPsych Open. 10:e60. 2024
- A genome-wide association, polygenic risk score and sex study on opioid use disorder treatment outcomes. Scientific Reports. 13:22360. 2023
- Association Between Mental Health Burden, Clinical Presentation, and Outcomes in Individuals With Symptomatic Peripheral Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 148:1511-1528. 2023
-
Association between the
COVID ‐19 pandemic and psychiatric symptoms in people with preexisting obsessive‐compulsive, eating, anxiety, and mood disorders: a systematic review and meta‐analysis of before‐after studies. Psychiatry and Clinical Neurosciences. 77:583-591. 2023 - Heterogeneity across outcomes reported in clinical trials for older adults with depression: a systematic survey. Journal of Clinical Epidemiology. 157:59-73. 2023
- Integrating Psychosocial Care in the Management of Patients With Vascular Disease. Journal of the American College of Cardiology. 81:1201-1204. 2023
- Genetics of cannabis use in opioid use disorder: A genome-wide association and polygenic risk score study. PLoS ONE. 18:e0289059-e0289059. 2023
- Factors Associated With Increased Opioid Use During the COVID-19 Pandemic: A Prospective Study of Patients Enrolled in Opioid Agonist Treatment. Journal of Addiction Medicine. 16:e257-e264. 2022
- Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis. Journal of Addiction Medicine. 16:e248-e256. 2022
- Cannabinoids in psychiatry: they are here to stay. The British journal of psychiatry. Supplement. 220:311-313. 2022
- Mirtazapine for the treatment of amphetamine and methamphetamine use disorder: A systematic review and meta-analysis. Drug and Alcohol Dependence. 232:109295-109295. 2022
- National suicide management guidelines recommending family-based prevention, intervention and postvention and their association with suicide mortality rates: systematic review. BJPsych Open. 8:e54. 2022
- Virtual psychiatric care fast-tracked: reflections inspired by the COVID-19 pandemic. BJPsych Bulletin. 46:33-36. 2022
- Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data. Frontiers in Psychiatry. 13:1046649. 2022
- The Inclusion of Patients’ Reported Outcomes to Inform Treatment Effectiveness Measures in Opioid Use Disorder. A Systematic Review. Patient Related Outcome Measures. Volume 13:113-130. 2022
- A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder. Addiction Science & Clinical Practice. 16:70. 2021
- Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada. Substance Abuse: Treatment, Prevention, and Policy. 16:34. 2021
- Delirium and other neuropsychiatric manifestations of COVID-19 infection in people with preexisting psychiatric disorders: a systematic review. Journal of Medical Case Reports. 15:586. 2021
- Factors affecting participant recruitment and retention in borderline personality disorder research: a feasibility study. Pilot and Feasibility Studies. 7:178. 2021
- Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?. Harm Reduction Journal. 18:71. 2021
- Identifying patient-important outcomes for treatment of bipolar disorder: a systematic review protocol. BMJ Open. 11:e050453-e050453. 2021
- Problematic Opioid Use Among Older Adults: Epidemiology, Adverse Outcomes and Treatment Considerations. Drugs and Aging. 38:1043-1053. 2021
- Sensitivity and specificity of self-reported psychiatric diagnoses amongst patients treated for opioid use disorder. BMC Psychiatry. 21:520. 2021
- The association between cannabis use and outcome in pharmacological treatment for opioid use disorder. Harm Reduction Journal. 18:24. 2021
- Corrigendum to ‘A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis’ [EClinicalMedicine 24 (2020) 100442]. EClinicalMedicine. 41:101182-101182. 2021
- Outcomes reported in randomised controlled trials of major depressive disorder in older adults: protocol for a methodological review. BMJ Open. 11:e054777-e054777. 2021
- Investigating and addressing the immediate and long-term consequences of the COVID-19 pandemic on patients with substance use disorders: a scoping review and evidence map protocol. BMJ Open. 11:e045946-e045946. 2021
- The Role of Cannabis Use in Suicidal Ideation Among Patients With Opioid Use Disorder. Journal of Addiction Medicine. 15:370-375. 2021
- Genetic basis of cannabis use: a systematic review. BMC Medical Genetics. 14:203. 2021
- Patient-Reported Goals of Youths in Canada Receiving Medication-Assisted Treatment for Opioid Use Disorder. JAMA network open. 4:e2119600-e2119600. 2021
- Trauma and post-traumatic stress disorder in patients treated for opioid use disorder: findings from a 12-month cohort study. BJPsych Open. 7:e138. 2021
- Are patients’ goals in treatment associated with expected treatment outcomes? Findings from a mixed-methods study on outpatient pharmacological treatment for opioid use disorder. BMJ Open. 11:e044017-e044017. 2021
- Association between vaping and health outcomes in patients with opioid use disorder: a systematic review protocol. BMJ Open. 11:e040349-e040349. 2021
- Exploring the Impact of Modifiable Factors on Serum BDNF in Psychiatric Patients and Community Controls. Neuropsychiatric Disease and Treatment. Volume 17:545-554. 2021
- Global prevalence of burnout among postgraduate medical trainees: a systematic review and meta-regression. CMAJ open. 9:E189-E200. 2021
- Implications of OPRM1 and CYP2B6 variants on treatment outcomes in methadone-maintained patients in Ontario: Exploring sex differences. PLoS ONE. 16:e0261201-e0261201. 2021
- Leading from Behind: An Educational Intervention to Address Faculty and Learner Preparedness for Competence By Design in Psychiatry. Journal of Multidisciplinary Healthcare. Volume 14:2587-2595. 2021
- The Role of Perceived Social Support in the Association Between Stressful Life Events and Suicidal Behavior. Frontiers in Psychiatry. 12:699682. 2021
- The future of precision medicine in opioid use disorder: inclusion of patient-important outcomes in clinical trials. Revista Brasileira de Psiquiatria. 43:138-146. 2021
- A call for consensus in defining efficacy in clinical trials for opioid addiction: combined results from a systematic review and qualitative study in patients receiving pharmacological assisted therapy for opioid use disorder. Trials. 21:30. 2020
- Exploring the Association between Cannabis Use and Testosterone Levels in Men Receiving Methadone Maintenance Treatment. Psychiatry International. 1:67-74. 2020
- Feasibility of behavioral activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial. Pilot and Feasibility Studies. 6:61. 2020
- GWAS-identified genetic variants associated with medication-assisted treatment outcomes in patients with opioid use disorder: a systematic review and meta-analysis protocol. Systematic Reviews. 9:200. 2020
- Genetic determinants of cannabis use: a systematic review protocol. Systematic Reviews. 9:190. 2020
- Reporting of methodological studies in health research: a protocol for the development of the MethodologIcal STudy reportIng Checklist (MISTIC). BMJ Open. 10:e040478-e040478. 2020
- Social functioning outcomes in men and women receiving medication-assisted treatment for opioid use disorder. Biology of Sex Differences. 11:20. 2020
- The association of HTR2A polymorphisms with obsessive-compulsive disorder and its subtypes: A meta-analysis. Journal of Affective Disorders. 275:278-289. 2020
- Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care. BMJ Open. 10:e040229-e040229. 2020
- Behavioural activation therapy for depression in adults. Clinical Respiratory Journal. 7:CD013305. 2020
- A comparison of electronically-delivered and face to face cognitive behavioural therapies in depressive disorders: A systematic review and meta-analysis. EClinicalMedicine. 24:100442-100442. 2020
- National suicide management guidelines with family as an interv’ention and suicide mortality rates: a systematic review protocol. BMJ Open. 10:e034694-e034694. 2020
- Evaluation of BDNF as a Biomarker for Impulsivity in a Psychiatric Population. Diagnostics. 10:419-419. 2020
- The impact of chronic liver disease in patients receiving active pharmacological therapy for opioid use disorder: One-year findings from a prospective cohort study. Drug and Alcohol Dependence. 209:107917-107917. 2020
- Canadian Guidelines on Opioid Use Disorder Among Older Adults. Canadian Geriatrics Journal. 23:123-134. 2020
- <p>Children and Youth Who Use Cannabis for Pain Relief: Benefits, Risks, and Perceptions</p>. Adolescent Health, Medicine and Therapeutics. Volume 11:53-61. 2020
- Exploring psychological symptoms and associated factors in patients receiving medication-assisted treatment for opioid-use disorder. BJPsych Open. 6:e8. 2020
- Psychosis and Comorbid Opioid Use Disorder: Characteristics and Outcomes in Opioid Substitution Therapy. Schizophrenia Bulletin Open. 1:sgaa007. 2020
- Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis. Frontiers in Psychiatry. 11:812. 2020
- Sociodemographic characteristics of patients with children in a methadone maintenance program: a cross-sectional study. Harm Reduction Journal. 16:13. 2019
- The association between health conditions and cannabis use in patients with opioid use disorder receiving methadone maintenance treatment. BJPsych Open. 5:e91. 2019
- Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis. CMAJ open. 7:E665-E673. 2019
- Feasibility and implementation of a healthy lifestyles program in a community setting in Ontario, Canada: protocol for a pragmatic mixed methods pilot study. BMJ Open. 9:e031298-e031298. 2019
- Adverse Outcomes Associated with Prescription Opioids for Acute Low Back Pain: A Systematic Review and Meta-Analysis. Pain Physician. 2:119-138. 2019
- Patient Experiences and Opinions of a Behavioral Activation Group Intervention for Depression. Research on Social Work Practice. 29:10-18. 2019
- A systematic review of comparisons between protocols or registrations and full reports in primary biomedical research. BMC Medical Research Methodology. 18:9. 2018
- Association Between Family Factors and Illicit Polysubstance Use Amongst Methadone Maintenance Patients with Opioid Use Disorder. International Journal of High Risk Behaviors and Addiction. 7. 2018
- Identifying patient-important outcomes in medication-assisted treatment for opioid use disorder patients: a systematic review protocol. BMJ Open. 8:e025059-e025059. 2018
- The association between cannabis use and suicidal behavior in patients with psychiatric disorders: an analysis of sex differences. Biology of Sex Differences. 9:22. 2018
- Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol. Systematic Reviews. 7:16. 2018
- Association Between Socio-Demographic and Health Functioning Variables Among Patients with Opioid Use Disorder Introduced by Prescription: A Prospective Cohort Study.. Pain Physician. 21:E623-E632. 2018
- A Systematic Survey of Control Groups in Behavioral and Social Science Trials. Research on Social Work Practice. 28:538-545. 2018
- Evaluating Completeness of Reporting in Behavioral Interventions Pilot Trials. Research on Social Work Practice. 28:577-584. 2018
- Enhancing primary reports of randomized controlled trials: Three most common challenges and suggested solutions. Proceedings of the National Academy of Sciences of the United States of America. 115:2595-2599. 2018
- Exploring metabolic factors and health behaviors in relation to suicide attempts: A case-control study. Journal of Affective Disorders. 229:386-395. 2018
- Does the medical literature remain inadequately described despite having reporting guidelines for 21 years? – A systematic review of reviews: an update. Journal of Multidisciplinary Healthcare. Volume 11:495-510. 2018
- Enhancing research publications and advancing scientific writing in health research collaborations: sharing lessons learnt from the trenches. Journal of Multidisciplinary Healthcare. Volume 11:245-254. 2018
- Exploring the characteristics, global distribution and reasons for retraction of published articles involving human research participants: a literature survey. Journal of Multidisciplinary Healthcare. Volume 11:39-47. 2018
- Profile of suicide attempts and risk factors among psychiatric patients: A case-control study. PLoS ONE. 13:e0192998-e0192998. 2018
- The effect of cannabis exposure on pubertal outcomes: a systematic review. Adolescent Health, Medicine and Therapeutics. Volume 9:137-147. 2018
- Volumetric MRI Analysis of a Case of Severe Ventriculomegaly. Frontiers in Human Neuroscience. 12:495. 2018
- A scoping review of comparisons between abstracts and full reports in primary biomedical research. BMC Medical Research Methodology. 17:181. 2017
- Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol. Systematic Reviews. 6:163. 2017
- Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences. Biology of Sex Differences. 8:8. 2017
- Sex differences in social risk factors for suicidal behaviour. Mental Health and Prevention. 8:1-6. 2017
- The association between age of onset of opioid use and comorbidity among opioid dependent patients receiving methadone maintenance therapy. Addiction Science & Clinical Practice. 12:9. 2017
- Acceptability of the Fitbit in behavioural activation therapy for depression: a qualitative study. Evidence-Based Mental Health. 20:128-133. 2017
- Influence of depression on genetic predisposition to type 2 diabetes in a multiethnic longitudinal study. Scientific Reports. 7:1629. 2017
- State of reporting of primary biomedical research: a scoping review protocol. BMJ Open. 7:e014749-e014749. 2017
- The Genetics of Opioid Addiction Risk Evaluation Tool (GREAT) for Treatment Response in Methadone Patients. International Journal of High Risk Behaviors and Addiction. 6. 2017
- Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities. Case Reports in Psychiatry. 2017:1-7. 2017
- The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatric Disease and Treatment. Volume 13:1399-1408. 2017
- “Don’t Judge a Book by Its Cover”: A Qualitative Study of Methadone Patients’ Experiences of Stigma. Substance Use: Research and Treatment. 11:117822181668508-117822181668508. 2017
- Association between cannabis use and treatment outcomes in patients receiving methadone maintenance treatment: a systematic review protocol. Systematic Reviews. 5:139. 2016
- Behavioral activation group therapy for reducing depressive symptoms and improving quality of life: a feasibility study. Pilot and Feasibility Studies. 2:22. 2016
- Body Mass Index Is an Important Predictor for Suicide: Results from a Systematic Review and Meta‐Analysis. Suicide and Life-Threatening Behavior. 46:697-736. 2016
- Efficacy and safety of psychostimulants for amphetamine and methamphetamine use disorders: a systematic review and meta-analysis. Systematic Reviews. 5:189. 2016
- Exploring the Association between Serum BDNF and Attempted Suicide. Scientific Reports. 6:25229. 2016
- Pain and Opioid Addiction: A Systematic Review and Evaluation of Pain Measurement in Patients with Opioid Dependence on Methadone Maintenance Treatment. Current Drug Research Reviews. 9:49-60. 2016
- Light therapy for non-seasonal depression: systematic review and meta-analysis. BJPsych Open. 2:116-126. 2016
- Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment. Pain Physician. 1;19:E181-E195. 2016
- Somatic symptom disorder, a new DSM-5 diagnosis of an old clinical challenge. BMJ Case Reports. 2016:bcr2015212553-bcr2015212553. 2016
- A Prospective Study to Investigate Predictors of Relapse among Patients with Opioid Use Disorder Treated with Methadone. Substance Use: Research and Treatment. 10:SART.S37030-SART.S37030. 2016
- Best (but oft-forgotten) practices: sensitivity analyses in randomized controlled trials. American Journal of Clinical Nutrition. 103:5-17. 2016
- Neuropsychological Impact of West Nile Virus Infection: An Extensive Neuropsychiatric Assessment of 49 Cases in Canada. PLoS ONE. 11:e0158364-e0158364. 2016
- Obesity Genes and Risk of Major Depressive Disorder in a Multiethnic Population. Journal of Clinical Psychiatry. 76:e1611-e1618. 2015
- A pragmatic pilot randomized trial to investigate the effectiveness of behavioural activation group therapy in reducing depressive symptoms and improving quality of life in patients with depression: the BRAVE pilot trial protocol. Pilot and Feasibility Studies. 1:39. 2015
- Association between BDNF levels and suicidal behaviour: a systematic review and meta-analysis. Systematic Reviews. 4:187. 2015
- Association between BDNF levels and suicidal behaviour: a systematic review protocol. Systematic Reviews. 4:56. 2015
- Association between body mass index and suicidal behaviors: a systematic review protocol. Systematic Reviews. 4:52. 2015
- Contribution of BDNF and DRD2 genetic polymorphisms to continued opioid use in patients receiving methadone treatment for opioid use disorder: an observational study. Addiction Science & Clinical Practice. 10:19. 2015
- Exploring the Determinants of Suicidal Behavior: Conventional and Emergent Risk (DISCOVER): a feasibility study. Pilot and Feasibility Studies. 1:17. 2015
- Opioid substitution and antagonist therapy trials exclude the common addiction patient: a systematic review and analysis of eligibility criteria. Trials. 16:475. 2015
- Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study. Biology of Sex Differences. 6:21. 2015
- The impact of chronic pain on opioid addiction treatment: a systematic review protocol. Systematic Reviews. 4:49. 2015
- Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic reviewand meta-analysis. CMAJ open. 3:E344-E351. 2015
- Lack of association between type 2 diabetes and major depression: epidemiologic and genetic evidence in a multiethnic population. Translational Psychiatry. 5:e618-e618. 2015
- Re-Examination of Classic Risk Factors for Suicidal Behavior in the Psychiatric Population. Crisis. 36:231-240. 2015
- Testosterone suppression in opioid users: A systematic review and meta-analysis. Drug and Alcohol Dependence. 149:1-9. 2015
- Impact of Chronic Pain on Treatment Prognosis for Patients with Opioid Use Disorder: A Systematic Review and Meta-analysis. Substance Use: Research and Treatment. 9:SART.S30120-SART.S30120. 2015
- Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol. Systematic Reviews. 3:45. 2014
- The effectiveness of opioid substitution treatments for patients with opioid dependence: a systematic review and multiple treatment comparison protocol. Systematic Reviews. 3:105. 2014
- Methadone induces testosterone suppression in patients with opioid addiction. Scientific Reports. 4:6189. 2014
- Commentary on ‘Elm et al’. Clinical Trials. 11:473-475. 2014
- An Overview of Pharmacogenetics in Psychotropic Drugs. Current Psychiatry Research and Reviews. 10:182-191. 2014
- Editorial (Thematic Issue: Genetics: A Window into the Biology of the Mind). Current Psychiatry Research and Reviews. 10:89-90. 2014
- Genetics of Opioid Dependence: A Review of the Genetic Contribution to Opioid Dependence. Current Psychiatry Research and Reviews. 10:156-167. 2014
- What is the role of Vitamin D in depression?. Psychiatric Times. 31. 2014
- Efficacy of Vitamin D Supplementation in Depression in Adults: A Systematic Review. Journal of Clinical Endocrinology and Metabolism (JCEM). 99:757-767. 2014
- Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation. Neuropsychiatric Disease and Treatment. 10:2239-2239. 2014
- Genetic influence on methadone treatment outcomes in patients undergoing methadone maintenance treatment for opioid addiction: a pilot study. Neuropsychiatric Disease and Treatment. 10:1503-1503. 2014
- Impact of ABCB1 and CYP2B6 Genetic Polymorphisms on Methadone Metabolism, Dose and Treatment Response in Patients with Opioid Addiction: A Systematic Review and Meta-Analysis. PLoS ONE. 9:e86114-e86114. 2014
- A tutorial on sensitivity analyses in clinical trials: the what, why, when and how. BMC Medical Research Methodology. 13:92. 2013
- Efficacy of vitamin D supplementation in depression in adults: a systematic review protocol. Systematic Reviews. 2:64. 2013
- Erratum: The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Molecular Psychiatry. 18:1324-1324. 2013
- The protective effect of the obesity-associated rs9939609 A variant in fat mass- and obesity-associated gene on depression. Molecular Psychiatry. 18:1281-1286. 2013
- South Asian Heart Risk Assessment (SAHARA): Randomized Controlled Trial Design and Pilot Study. JMIR Research Protocols. 2:e33-e33. 2013
- Vitamin D deficiency and depression in adults: systematic review and meta-analysis. The British journal of psychiatry. Supplement. 202:100-107. 2013
- A systematic scoping review of adherence to reporting guidelines in health care literature. Journal of Multidisciplinary Healthcare. 6:169-169. 2013
- The role of the serotonergic system in suicidal behavior. Neuropsychiatric Disease and Treatment. 9:1699-1699. 2013
- Smoking Cessation Intervention in a Cardiovascular Hospital Based Clinical Setting. Cardiovascular Psychiatry and Neurology. 2012:1-7. 2012
- The association of attempted suicide with genetic variants in the SLC6A4 and TPH genes depends on the definition of suicidal behavior: a systematic review and meta-analysis. Translational Psychiatry. 2:e166-e166. 2012
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and select comorbid medical conditions.. Annals of Clinical Psychiatry. 24:91-109. 2012
- Does Depression Impact Cognitive Impairment in Patients with Heart Failure?. Cardiology Research and Practice. 2012:1-9. 2012
- Methylenetetrahydrofolate Reductase Gene Variant (MTHFR C677T) and Migraine: A Case Control Study and Meta-analysis. BMC Neurology. 11:66. 2011
- Diagnosing migraine in research and clinical settings: The validation of the Structured Migraine Interview (SMI). BMC Neurology. 10:7. 2010
- Effectiveness of an Online Pediatric Primary Care Curriculum. Academic Pediatrics. 10:131-137. 2010
- Depression, Migraine With Aura and Migraine Without Aura: Their Familiality and Interrelatedness. Cephalalgia. 29:848-854. 2009
- Migraine in recurrent depression: case–control study. The British journal of psychiatry. Supplement. 194:350-354. 2009
- Factitious disorder presenting as type 1 diabetes mellitus. BMJ Case Reports. 2009:bcr0720080463-bcr0720080463. 2009
- A postmenopausal woman presenting with Ekbom syndrome associated with recurrent depressive disorder: a case report. Cases Journal. 1:54. 2008
- Depression, migraine, and cardiovascular disease: Sadness really can break your heart. Journal of Psychosomatic Research. 65:103-106. 2008
- Subacute alteration in level of consciousness in a woman with psychotic depression.. Journal of Psychiatry & Neuroscience. 33:E1-E2. 2008
-
preprints
- Factors Associated with Opioid Overdose During Medication-Assisted Treatment: How Can We Identify Individuals at Risk? 2020
- A Call for Consensus in Defining Efficacy in Clinical Trials for Opioid Addiction: Combined Results from a Systematic Review and Qualitative Study in Patients Receiving Pharmacological Assisted Therapy for Opioid Use Disorder 2019
- A Call for Consensus in Defining Efficacy in Clinical Trials for Opioid Addiction: Combined Results from a Systematic Review and Qualitative Study in Patients Receiving Pharmacological Assisted Therapy for Opioid Use Disorder 2019
- Full A Call for Consensus in Defining Efficacy in Clinical Trials for Opioid Addiction: Combined Results from a Systematic Review and Qualitative Study in Patients Receiving Pharmacological Assisted Therapy for Opioid Use Disorder 2019